Glow Protocol vs NAD+
Limited Research vs Extensively Studied
compatible Different mechanisms may complement cellular energy support
Molecular Data
Glow Protocol NAD+
Weight — 663.43 Da
Half-life — 1-4 hours (intracellular)
Type Fixed-ratio peptide combination Coenzyme
Key Benefits
Glow Protocol
01 Single injection delivers multiple regenerative peptides
02 Theoretical additive effects from combined components
03 Convenience factor versus individual peptide administration
NAD+
01 Restores mitochondrial function and ATP synthesis
02 Enhances glucose and fat metabolism
03 Improves oxygen utilization and endurance
04 Activates DNA repair mechanisms
05 Supports longevity pathways via sirtuins
06 Improves mental clarity and focus
Dosing Protocols
Glow Protocol
Per formulation instructions (typically 50mg GHK-Cu, 10mg TB-500, 10mg BPC-157 per dose) / Once daily
Standard protocol Per formulation instructions Once daily
NAD+
IV: 250-1000mg; IM/SubQ: 100-500mg; Intranasal: 25-50mg; Oral precursors: 100-500mg NMN/NR / IV: 1-2x weekly; IM/SubQ: 2-3x weekly; Intranasal: 1-2x daily; Oral: daily
IV Infusion 250-1000mg 1-2x weekly
IM/SubQ 100-500mg 2-3x weekly
Side Effects
Glow Protocol
Injection site reactions
Temporary blue-green discoloration (from GHK-Cu)
NAD+
Mild flushing during IV infusion
Temporary nausea
Contraindications
IV administration requires medical supervision
Avoid alcohol during treatment
Maintain consistent dosing schedule
Research Evidence
Glow Protocol NAD+
Status Limited Research Extensively Studied
References 3 studies 4 studies
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.